GlassScriptPhysician profile
Phillip H Horne
NPI 1073757720
$45,099.54
in general payments reported to CMS, 2019-2025
11 companies · $5,424 in 2025
The $5,424 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,247 · 2020: $1,440 · 2021: $18K · 2022: $7,843 · 2023: $3,427 · 2024: $6,908 · 2025: $5,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5,666 · Consulting Fee: $4,400 · Travel and Lodging: $3,252 · Food and Beverage: $2,180 · Education: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,665.72 |
| Consulting Fee | $4,400.00 |
| Travel and Lodging | $3,252.01 |
| Food and Beverage | $2,180.08 |
| Education | $261.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $35,895.95 | 2019-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Orbit-R Anterior Lumbar Disc |
| Restor3d, INC. | $5,665.72 | 2023-2025 | |
| Abbott Laboratories | $1,492.41 | 2023-2024 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,022.09 | 2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $512.94 | 2023-2025 | Intellis Adaptivestim, Mazor X System, Inceptiv |
| Cerapedics INC. | $261.40 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Nuvasive, INC. | $141.74 | 2019-2023 | Acp |
| Nevro Corp. | $46.26 | 2023 | Senza |
| Intrinsic Therapeutics | $27.03 | 2025 | Barricaid Acd (Annular Closure Device) |
| Medical Device Business Services, INC. | $20.45 | 2025 | Teligen |
| Providence Medical Technology, INC. | $13.55 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$180,537.93 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Horne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.